Expression of concern to "Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study" [EJOG 165(2) (2012) 254-258]

Eur J Obstet Gynecol Reprod Biol. 2024 Aug:299:302. doi: 10.1016/j.ejogrb.2024.06.009. Epub 2024 Jun 7.
No abstract available

Publication types

  • Letter
  • Expression of Concern

MeSH terms

  • Dopamine Agonists* / administration & dosage
  • Dopamine Agonists* / therapeutic use
  • Female
  • Humans
  • Ovarian Hyperstimulation Syndrome* / prevention & control
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Sperm Injections, Intracytoplasmic*

Substances

  • Dopamine Agonists